Value Assessment Frameworks in the United States: A Call for Patient Engagement Vakaramoko DiabyAskal A. AliAlberto J. Montero Editorial Open access 04 September 2018 Pages: 1 - 3
Conducting a Time Trade-Off Study Alongside a Clinical Trial: A Case Study and Recommendations Jing ShenSarah HillRob Pickard Practical Application Open access 15 June 2018 Pages: 5 - 20
Systematic Review of Economic Models Used to Compare Techniques for Detecting Peripheral Arterial Disease Eoin MoloneyJoanne O’ConnorJohn Allen Systematic Review Open access 23 April 2018 Pages: 21 - 30
Accommodation and Health Costs of Deinstitutionalized People with Mental Illness Living in Residential Services in Brazil Denise Razzouk Original Research Article Open access 30 April 2018 Pages: 31 - 42
Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with Advanced Melanoma in England D. LeeA. AmadiY. Meng Original Research Article Open access 22 May 2018 Pages: 43 - 54
Reduction of Direct Health Costs Associated with Pertussis Vaccination with Acellular Vaccines in Children Aged 0–9 Years with Pertussis in Catalonia (Spain) Pedro Plans-RubióEncarna NavasPedro Brotons Original Research Article Open access 14 May 2018 Pages: 55 - 69
Assessing the Impact of Growth Hormone Deficiency (GHD) in Adults: Interpreting Change of the Treatment-Related Impact Measure—Adult Growth Hormone Deficiency (TRIM-AGHD) Meryl BrodJane F. BeckMichael Højby Rasmussen Original Research Article Open access 23 May 2018 Pages: 71 - 80
Influence of Idiopathic Pulmonary Fibrosis Progression on Healthcare Resource Use Alex DiamantopoulosToby M. MaherCorinne LeReun Original Research Article Open access 25 June 2018 Pages: 81 - 91
Cost Effectiveness of Long-Term Incobotulinumtoxin-A Treatment in the Management of Post-stroke Spasticity of the Upper Limb from the Australian Payer Perspective Koji MakinoDominic TildenIan J. Baguley Original Research Article Open access 18 June 2018 Pages: 93 - 102
International HTA Experience with Targeted Therapy Approvals for Lung Cancer Fatma MaraikiJ. ByrnesM. Hinder Original Research Article Open access 03 August 2018 Pages: 103 - 117
Evaluation of the Impact of an Institution-Specific Dofetilide Initiation Protocol on Mean Hospital Length of Stay and Cost for Dofetilide Initiation Steven P. KennedyHanna IaizzoDalip Singh Original Research Article Open access 18 April 2018 Pages: 119 - 126
Correction to: Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with Advanced Melanoma in England D. LeeA. AmadiY. Meng Correction Open access 11 September 2018 Pages: 127 - 127